# Infinity Pharmaceuticals (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/infinity-pharmaceuticals-united-states/

## Facts

| Field | Value |
| --- | --- |
| Citations | 132,065 |
| City | Cambridge |
| Country | US |
| Description | Infinity Pharmaceuticals (United States) is a research organisation in Cambridge, US. OpenAlex records 286 works and 132,065 citations for it. 94 researchers list it as their most recent affiliation. |
| Homepage | http://www.infi.com/ |
| OpenAlex ID | https://openalex.org/I4210108457 |
| Region | Massachusetts |
| Researchers | 94 |
| ROR ID | https://ror.org/01sfsq511 |
| Type | company |
| Works | 286 |

## University top topics

Showing 8 of 25.

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Hedgehog Signaling Pathway Studies](https://scholariq.org/topics/hedgehog-signaling-pathway-studies/)
- [Heat shock proteins research](https://scholariq.org/topics/heat-shock-proteins-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.